drugs. Do not substitute Herceptin (trastuzumab) for or with ado-trastuzumab emtansine. Adjuvant Treatment, Breast Cancer.
Trastuzumab is an antibody drug that specially target HER2-positive cancer cells. Trastuzumab attaches to the HER2 protein on the surface of
This intravenous drug combines trastuzumab with a chemotherapy drug called emtansine. Trastuzumab delivers emtansine directly to the HER2-positive cancer cells.
For more information about pertuzumab and trastuzumab that may apply to pertuzumab, trastuzumab, and hyaluronidase-zzxf, see the Drug Information Summaries for Pertuzumab and Trastuzumab. More About Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf. Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this
Outline TH (paclitaxel and trastuzumab) TCH (docetaxel, carboplatin, and trastuzumab) TCHP (trastuzumab, pertuzumab, carboplatin, and
Trastuzumab is an antibody drug that specially target HER2-positive cancer cells. Trastuzumab attaches to the HER2 protein on the surface of
Targeted therapy drugs for HER2-positive breast cancer Trastuzumab Pertuzumab Pertuzumab and trastuzumab Trastuzumab emtansine Trastuzumab deruxtecan.
Trastuzumab emtansine (Kadcyla). Trastuzumab emtansine (Kadcyla) is a combination of 2 drugs: trastuzumab; a chemotherapy drug called emsatine after surgery.
To prevent medication errors, check the vial labels to ensure that the drug is trastuzumab and not trastuzumab emtansine. HER2 testing is
Comments